Figure F-46 is titled “PTSD symptom reduction for CBT-mixed compared with control.” This figure displays a forest plot reporting the standardized mean difference of PTSD symptom reduction stratified by CBT-mixed compared to usual care and CBT-mixed compared to waitlist. The plot depicts greater reductions in PTSD symptoms for patients treated with CBT-mixed than usual care (1 trial, standardized mean difference −0.33, 95% CI −0.80 to 0.14) or waitlist (13 trials, standardized mean difference −1.16, 95% CI −1.47 to −0.84, I2 = 72.7%). The overall analysis favored CBT-mixed (standardized mean difference −1.09, 95% CI −1.40 to −0.78, I2 =75.3%).

Figure F-46PTSD symptom reduction for CBT-mixed compared with control

Timing of outcome assessment: 7 weeks (Johnson, 2011), 8 to 12 weeks (Blanchard, 2003), 12 weeks (Cloitre, 2002), 4 weeks (Fecteau, 1999), 12 weeks (Foa, 2005), 9 weeks (Foa, 1999), 12 weeks (Hinton, 2005), 12 weeks (Hollifield, 2007) 4 to 5.5 weeks (Kubany, 2004), 4.5 months (Kubany, 2003), 4.8 months (Liedl, 2011), 14 weeks (McDonagh, 2005), 8 weeks (Spence, 2011), 5 sessions (van Emmerik, 2008).

From: Appendix F, Meta-Analysis

Cover of Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD)
Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD) [Internet].
Comparative Effectiveness Reviews, No. 92.
Jonas DE, Cusack K, Forneris CA, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.